about
Generation of stable co-cultures of vascular cells in a honeycomb alginate scaffold.Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2Exploratory clinical trial of combination wound therapy with a gelatin sheet and platelet-rich plasma in patients with chronic skin ulcers: study protocol.Tissue engineering by modulated gene delivery.Scaffold biomaterials for nano-pathophysiology.Fabrication of hydrogels with elasticity changed by alkaline phosphatase for stem cell culture.Expression profile of plasmid DNA obtained using spermine derivatives of pullulan with different molecular weights.Safety and efficacy of sustained release of basic fibroblast growth factor using gelatin hydrogel in patients with critical limb ischemia.Effect of amine type on the expression of plasmid DNA by cationized dextran.Basic fibroblast growth factor combined with biodegradable hydrogel promotes healing of facial nerve after compression injury: an experimental study.Comparative physicochemical properties and cytotoxicity of polyphosphoester ionomers with bisphosphonates.Skull bone regeneration in nonhuman primates by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel.Control-released hepatocyte growth factor prevents the progression of heart failure in stroke-prone spontaneously hypertensive rats.Vascularization into a porous sponge by sustained release of basic fibroblast growth factor.Degree of biological apatite c-axis orientation rather than bone mineral density controls mechanical function in bone regenerated using recombinant bone morphogenetic protein-2.Mineralization, biodegradation, and drug release behavior of gelatin/apatite composite microspheres for bone regeneration.In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds.Enhanced ectopic bone formation using a combination of plasmid DNA impregnation into 3-D scaffold and bioreactor perfusion culture.Intrapleural administration of gelatin-embedded, sustained-release basic fibroblast growth factor for the regeneration of emphysematous lungs in rats.Angiogenesis induced by controlled release of neuropeptide substance P.Fast and effective mitochondrial delivery of ω-Rhodamine-B-polysulfobetaine-PEG copolymers.Safety and durability of the biodegradable felt in aortic surgery: a propensity score-matched study.Effect of hydrogel elasticity and ephrinB2-immobilized manner on Runx2 expression of human mesenchymal stem cells.Design of magnetic gene complexes as effective and serum resistant gene delivery systems for mesenchymal stem cells.Blood permeability of a novel ceramic scaffold for bone morphogenetic protein-2.Enhanced bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel.Osteogenic differentiation of mesenchymal stem cells in biodegradable sponges composed of gelatin and beta-tricalcium phosphate.Carrier dependent cell differentiation of bone morphogenetic protein-2 induced osteogenesis and chondrogenesis during the early implantation stage in rats.Complete tissue coverage achieved by scaffold-based tissue engineering in the fetal sheep model of Myelomeningocele.Controlled release of matrix metalloproteinase 1 with or without skeletal myoblasts transplantation improves cardiac function of rat hearts with chronic myocardial infarction.Combination of BMP-2-releasing gelatin/β-TCP sponges with autologous bone marrow for bone regeneration of X-ray-irradiated rabbit ulnar defects.Administration of control-released hepatocyte growth factor enhances the efficacy of skeletal myoblast transplantation in rat infarcted hearts by greatly increasing both quantity and quality of the graft.Repairing of rabbit skull defect by dehydrothermally crosslinked collagen sponges incorporating transforming growth factor beta1Bone regeneration by transforming growth factor beta1 released from a biodegradable hydrogelBone regeneration at rabbit skull defects treated with transforming growth factor-beta1 incorporated into hydrogels with different levels of biodegradabilityUltrastructure of the interface between cultured osteoblasts and surface-modified polymer substratesPrevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantationUse of collagen sponge incorporating transforming growth factor-beta1 to promote bone repair in skull defects in rabbitsImproved therapeutic efficacy in cardiomyocyte transplantation for myocardial infarction with release system of basic fibroblast growth factorLiver targeting of plasmid DNA with a cationized pullulan for tumor suppression
P50
Q30501466-33853B99-B025-4B73-A6D4-42F71233ABD1Q34480036-0FE6C3BF-035C-441F-8E73-6C5F1CC69744Q35604896-EF705224-13AB-4F42-8B88-B3D60036E35CQ36500666-D8F1789C-B1EB-4EE8-B97F-9614F673EFF5Q38146216-F810F4A0-C972-4307-A270-6D34D93F6F1BQ38822879-18B19B01-E7EB-4A34-B3AB-42DDE000CB2AQ40096205-880BDF20-665D-4953-8DAA-B65294229DC4Q41090665-574F09AE-0442-430D-9AAF-D5374EAE0090Q43186973-917695DD-D241-4D0D-B904-3C496F8A8A71Q43441856-5C819D7D-D9B7-40A6-BC57-6966DC103BC1Q43797851-81E3570B-1E92-492E-8B17-0AE0A34F089AQ44076808-F849C9D1-5612-4E3B-A4E3-2D177FB7C0BEQ44730117-15A63862-E6ED-4A49-8AC0-8D9B84E5D4D1Q46136525-5B1C9A91-A35D-4197-9D03-1DEDE8BAE697Q46289354-5B8D6548-405D-446E-B5E1-2156DF80E72CQ46295746-32D6E2D7-93A1-4A97-99B4-939CC463FF7AQ46458076-D8932A32-96DB-4C24-8678-6C45C8F6230DQ46684690-E0A66754-0F51-48E4-A441-3B212F39E145Q46844234-7852FF16-5E28-415F-A5A9-52C3881A0048Q46986756-522DFEBC-CE37-4464-A31D-E6632BA5E4B3Q49432739-252A58E6-A3F9-409C-B257-3A4F8FD8D56CQ50132997-ADFA5D9E-7729-4AED-A146-70536FB665C8Q50956803-9ACC3AC5-CBD5-478C-9F02-E3276703382CQ51025931-2414FFC9-0685-4E78-B75F-C95C321A42D9Q51120789-97AD2EC5-F14A-4FCB-9A8D-E02A3B877DF0Q51181570-036FE2E4-C888-469F-8BCF-6DD386D0666AQ51561591-2F4208DE-D200-4956-AF18-2F100EC7312FQ51615808-B5F1273F-93C7-4323-A0FE-FBB22BD710CAQ51664850-E4CE4054-EB8D-4E1D-AE4D-D8F82104D2B7Q51822391-83AE8EB5-6AE1-4C10-9FC2-2A7DB9FD117CQ53521795-DBFF13B2-369E-4C4D-9C7B-C522A5CD7B76Q53657455-BCE3E7F0-A3E0-40D4-91DC-C55FA816EA99Q72998356-26746BE1-7B69-4250-B244-FA9B97FC9CD6Q73367983-E6B05FF7-0802-4C0E-A437-719B0FEC0C96Q73410070-F1589947-792A-4AED-A6B8-47F016CF9415Q73799515-C13F346A-2BDB-4BFA-857B-3E3775097BD9Q74390765-583D6497-6493-4072-B88E-7C0F2E90165EQ77490706-4FF058E5-B263-4EBE-9192-CF082A2A78AAQ78966466-B749D792-A001-4B57-8716-E84BEE2AFF0EQ79265227-E8F3D96D-0FFC-4237-90A2-5BDAF17ABA7A
P50
description
researcher
@en
name
Masaya Yamamoto
@en
Masaya Yamamoto
@nl
type
label
Masaya Yamamoto
@en
Masaya Yamamoto
@nl
prefLabel
Masaya Yamamoto
@en
Masaya Yamamoto
@nl
P106
P31
P496
0000-0003-0271-291X